Innovation Radar

ABCardionostics at the NSFA Congress 2026 (Biarritz)

Leave a Comment / Actualités /

The ABCardionostics project represented by the CRMSB team was present at the NSFA Congress 2026, held in Biarritz, a key French meeting bringing together researchers and clinicians working on atherosclerosis and cardiovascular disease. Within the project, this work is part of Work Package 1, which focuses on understanding how different populations of monocytes and macrophages […]

ABCardionostics at the NSFA Congress 2026 (Biarritz) Read More »

Dr Florence Ottones successfully defends her HDR at the University of Bordeaux

Leave a Comment / Actualités /

On March 25, 2026, Dr Florence Ottones, member of the ABCardionostics project coordination team at CRMSB – University of Bordeaux, successfully defended her Habilitation to Direct Research (HDR) in Life and Health Sciences. The HDR is a major academic qualification in the French research system. It certifies a researcher’s ability to conduct and lead independent

Dr Florence Ottones successfully defends her HDR at the University of Bordeaux Read More »

CRMSB Team at TBI (Toulouse Biotechnology Institute) for Key Biochip Development

Leave a Comment / Actualités /

From 2 to 4 February, members of the CRMSB team (Université de Bordeaux) travelled to Toulouse to work with our partner TBI on the development of custom-made biochips, a key tool for the next phase of the ABCardionostics project. These biochips are designed to host and test scFv-Fc antibodies developed within the project, enabling the

CRMSB Team at TBI (Toulouse Biotechnology Institute) for Key Biochip Development Read More »

ABCardionostics innovations featured on the European Commission’s Innovation Radar

Leave a Comment / Actualités /

The ABCardionostics project is pleased to announce that several of its key innovations have been selected and published on the European Commission’s Innovation Radar platform. This recognition highlights the strong innovation capacity of the project and its potential to generate impactful solutions in the field of cardiovascular diagnostics and therapeutics. Following an independent assessment by

ABCardionostics innovations featured on the European Commission’s Innovation Radar Read More »